Researchers at Adelaide University in Australia are conducting research into the application of dental pulp stem cells to treat neurological damage due to stroke. Cell based treatments for the detrimental effects of stroke could improve quality of life by promoting neural regeneration, neuroplasticity, vascularization and immuno-modulation. When an ischemic stroke occurs, a major artery in the brain becomes blocked due to a blood clot, and this deprives part of the brain of nutrients and oxygen. Depending on the length of the block, major parts of the brain can suffer neuronal death causing severe and permanent damage. This damage includes paralysis, vision problems, memory loss and language difficulties. Currently, there are no effective treatments for the effects of stroke, and because dental stem cells are derived from the neural crest during embryonic development, a dental stem cell based treatment shows promise in significantly improving the quality of life for stroke victims.
The trial aims to determine the efficacy and safety of the application of dental pulp mesenchymal stem cells on patients who sustained neurological damage and therefore suffer from chronic disability because of stroke. They have recruited 27 patients with middle cerebral artery ischemic stroke and will monitor them following an intracranial injection of cultured dental stem cells to repair the neurological damage.
With clinical trials soon underway, this advancement in bioengineering will accelerate this trend and broaden applications to treat a wider variety of ailments. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.